142 related articles for article (PubMed ID: 14959844)
21. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
22. Signalling pathways activated by all-trans-retinoic acid in acute promyelocytic leukemia cells.
Kambhampati S; Verma A; Li Y; Parmar S; Sassano A; Platanias LC
Leuk Lymphoma; 2004 Nov; 45(11):2175-85. PubMed ID: 15512805
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation in acute promyelocytic leukemia.
Lin RJ; Sternsdorf T; Tini M; Evans RM
Oncogene; 2001 Oct; 20(49):7204-15. PubMed ID: 11704848
[TBL] [Abstract][Full Text] [Related]
24. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
Hong SH; David G; Wong CW; Dejean A; Privalsky ML
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
[TBL] [Abstract][Full Text] [Related]
25. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia.
So CW; Dong S; So CK; Cheng GX; Huang QH; Chen SJ; Chan LC
Leukemia; 2000 Jan; 14(1):77-83. PubMed ID: 10637480
[TBL] [Abstract][Full Text] [Related]
26. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
27. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
28. Retinoid target genes in acute promyelocytic leukemia.
Pitha-Rowe I; Petty WJ; Kitareewan S; Dmitrovsky E
Leukemia; 2003 Sep; 17(9):1723-30. PubMed ID: 12970771
[TBL] [Abstract][Full Text] [Related]
29. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
30. Transcription therapy for acute promyelocytic leukaemia.
Douer D
Expert Opin Investig Drugs; 2000 Feb; 9(2):329-46. PubMed ID: 11060680
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.
Zhu J; Gianni M; Kopf E; Honoré N; Chelbi-Alix M; Koken M; Quignon F; Rochette-Egly C; de Thé H
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14807-12. PubMed ID: 10611294
[TBL] [Abstract][Full Text] [Related]
32. Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation.
Zhao Q; Tao J; Zhu Q; Jia PM; Dou AX; Li X; Cheng F; Waxman S; Chen GQ; Chen SJ; Lanotte M; Chen Z; Tong JH
Leukemia; 2004 Feb; 18(2):285-92. PubMed ID: 14628075
[TBL] [Abstract][Full Text] [Related]
33. Activation of
Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
[TBL] [Abstract][Full Text] [Related]
34. Recurrent
Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
[TBL] [Abstract][Full Text] [Related]
35. Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.
Chen H; Pan J; Yao L; Wu L; Zhu J; Wang W; Liu C; Han Q; Du G; Cen J; Xue Y; Wu D; Sun M; Chen S
Cancer Genet; 2012 Jun; 205(6):327-31. PubMed ID: 22749039
[TBL] [Abstract][Full Text] [Related]
36. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
37. Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
Coltella N; Valsecchi R; Ponente M; Ponzoni M; Bernardi R
Clin Cancer Res; 2015 Aug; 21(16):3685-94. PubMed ID: 25931453
[TBL] [Abstract][Full Text] [Related]
38. Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor.
Higuchi T; Kizaki M; Omine M
Leuk Res; 2004 May; 28(5):525-32. PubMed ID: 15068906
[TBL] [Abstract][Full Text] [Related]
39. Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia.
Sternsdorf T; Phan VT; Maunakea ML; Ocampo CB; Sohal J; Silletto A; Galimi F; Le Beau MM; Evans RM; Kogan SC
Cancer Cell; 2006 Feb; 9(2):81-94. PubMed ID: 16473276
[TBL] [Abstract][Full Text] [Related]
40. Acute promyelocytic leukemia as a model for cross-talk between interferon and retinoic acid pathways: from molecular biology to clinical applications.
Gaboli M; Gandini D; Delva L; Wang ZG; Pandolfi PP
Leuk Lymphoma; 1998 Jun; 30(1-2):11-22. PubMed ID: 9669672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
